Intervenn Biosciences was co-founded by faculty members at Stanford University and University of California, Berkeley.

SoftBank and Heritage Provider Network were among the investors who co-led a series C round for Intervenn Biosciences, which is developing precision medicine.

Tiger Global has led another round for Infra.Market, having done the same six months ago when Sistema Asia Fund also invested.

SoftBank helped the raw materials procurement company secure $160m in a series E round, which will finance its acquisition strategy.

The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.

The developer of T-cell receptor therapies backed by Boehringer Ingelheim raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

SoftBank and PayPal helped the payments platform raise a series B round, which will be used to further boost the expansion of its digital ecosystem.

SoftBank Vision Fund has returned to back the e-learning portal in a round which valued it at $3.44bn and lifted its overall funding to about $860m.